Adverum Biotechnologies Inc.

In News

Lilly to Acquire Adverum Biotechnologies - PR Newswire

PR Newswire - Oct 24, 2025

Lilly to Acquire Adverum Biotechnologies | Eli Lilly and Company - Eli Lilly

Eli Lilly - Oct 24, 2025

Adverum Biotechnologies Announces Completion of Screening for Pivotal Phase 3 ARTEMIS Trial of Ixo-vec for Wet Age-Related Macular Degeneration - GlobeNewswire

GlobeNewswire - Sep 22, 2025

Trexquant Slashes Stake in Adverum Biotechnologies, Inc. (ADVM) - Yahoo Finance

Yahoo Finance - Sep 21, 2025

Adverum, hammered by gene therapy downturn, sells to Lilly in unusual deal - BioPharma Dive

BioPharma Dive - Oct 24, 2025

Eli Lilly bets on eye care with buyout of gene therapy developer Adverum - Reuters

Reuters - Oct 24, 2025

Lilly to purchase Adverum Biotechnologies - Eyes On Eyecare

Eyes On Eyecare - Oct 29, 2025

Lilly to Buy Adverum in Bet on Gene Therapy for Eye Disease - Bloomberg.com

Bloomberg.com - Oct 24, 2025

Shareholder Alert: The Ademi Firm investigates whether Adverum Biotechnologies, Inc. is obtaining a Fair Price for its Public Shareholders - Morningstar

Morningstar - Oct 24, 2025

ADVM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Adverum Biotechnologies, Inc. Is Fair to Shareholders - Business Wire

Business Wire - Oct 27, 2025

Eli Lilly Moves Forward With Acquisition Of Adverum Biotechnologies - Nasdaq

Nasdaq - Dec 09, 2025

Eli Lilly completes acquisition of Adverum Biotechnologies - Seeking Alpha

Seeking Alpha - Dec 09, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment